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Abstract
Background: Cell based therapies are required now to meet the critical care needs of paediatrics and healthy ageing in an
increasingly long-lived human population. Repair of compromised tissue by supporting autologous regeneration is a life
changing objective uniting the fields of medical science and engineering. Adipose stem cells (adSCs) are a compelling
candidate for use in cell based medicine due to their plasticity and residence in numerous tissues. Adipose found in all
animals contains a relatively high concentration of stem cells and is easily isolated by a minimally invasive clinical
intervention; such as liposuction.
Methods: This study utilised primary rat adipose to validate a novel strategy for selecting adult stem cells. Experiments
explored the use of large, very dense cell-specific antibody loaded isolation beads (diameter 5x–10x greater than target
cells) which overcome the problem of endocytosis and have proved to be very effective in cell isolation from minimally
processed primary tissue. The technique also benefited from pH mediated release, which enabled elution of captured cells
using a simple pH shift.
Results: Large beads successfully captured and released adSCs from rat adipose, which were characterised using a
combination of microscopy, flow cytometry and PCR. The resultant purified cell population retains minimal capture artefact
facilitating autologous reperfusion or application in in vitro models.
Conclusion: Although evidenced here for adSCs, this approach provides a technological advance at a platform level;
whereby it can be applied to isolate any cell population for which there is a characterised surface antigen.
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Introduction
Stem cell niches exist within almost all tissues of an adult
organism; their function to specifically localise and differentiate
into a specific type of cell to renew and repair the tissue in which
they reside has been realised scientifically [1,2]. However, a
fundamental cellular and biochemical understanding of the precise
mechanisms behind their physiological functions are yet to be
defined, and therefore hampers our ability to harness their
potential in efficacious and cost effective medicine [3]. Stem cells
have been successfully isolated from a diverse range of tissues,
including bone marrow [4–6], pancreas [7], adipose [8,6], dental
pulp [9–11] and umbilical tissues [12–13] and their multilineage
potential demonstrated through directed differentiation and
functionalisation into representatives from all three developmental
germ layers; a characteristic historically reserved solely for stem
cells of embryonic origin [14–16].
Extracting stem cells from their associated tissue in a manner
which renders them viable, phenotypically stable and suitable for
therapeutic application has presented a major challenge to the
field of cell biology but offers a tantalising omnipotent cell source
for regenerative medicine [17]. When considering sources of stem
cells, lipoaspirate presents itself as a favourable, readily accessible
supply, which can be obtained through minimally invasive
procedures, without donor site morbidity [18–19]. Additionally,
the concentration of stem cells within adipose has been reported to
be significantly higher than bone marrow [20]. Coupled with the
large quantities of lipoaspirate that can be harvested at any one
time, adipose may be considered as a future gold standard stem
cell source. Immunophenotyping of cultured adSCs has also
revealed .90% similarity with bone marrow-derived stem cells
including CD90, CD29, CD44, CD73 and CD105 cell surface
antigens [20–21].
Isolation of stromal vascular fraction (SVF) from rat adipose was
first achieved by Rodbell et al. in the 1960 s. Despite this, the
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notion of adSCs was not widely recognised until 2001 when Zuk
et al. demonstrated SVF contained large numbers of adSCs, which
could differentiate into osteogenic, chondrogenic, adipogenic and
myogenic lineages [22]. To date, the majority of approaches for
isolating adSCs from SVF are based on the same basic principle;
exploiting the ability of adSCs to adhere to plasma treated tissue
culture polystyrene substrates. However, this simple but crude
approach leads to a heterogeneous culture that contains a variety
of adherent cells which includes fibroblasts and endothelial cells,
ultimately resulting in a population of which adSCs are a minority
[23].
The phenotypic, functional and particularly immunomodulato-
ry effects of prolonged adSC in vitro culture are not fully
understood, therefore robust and reproducible characterisation
of freshly isolated adSCs would present a breakthrough in
interpreting complex adSC cell biology. However this has largely
been hindered by their rarity and the ability to isolate substantial
numbers from fresh tissue to perform immediate and reproducible
molecular biology. Several methods are available to isolate adSCs
and other primary cells. Currently the two most commonly
applied techniques are cell sorting by flow cytometry and
paramagnetic particle isolation, both of which allow selection of
cells based on antibody/antigen immunolabelling. Flow cytometry
utilises fluidic processing to localise target cells into drops or
diverted pathways. There are however significant hydrodynamic
forces associated with this, which stem cells in particular are
affected by. Magnetic particles currently in use are
50 nm24.5 mm diameter, to which cell-specific antibodies are
attached. These bind cells, which then become decorated with the
particles; the complexes are subsequently exposed to a magnetic
field resulting in separation of specific tagged cells from a
heterogeneous cell population. This provides a convenient method
of selecting cells; however the very small size of the paramagnetic
particles means they are typically internalised into the cell,
resulting in potential phenotypic changes [23]. Additionally, these
small particles are not compatible with the dense proteinaceous
matrix of primary tissue where they are observed to bind strongly
to tissue materials and even air bubbles (unpublished observa-
tions): therefore extensive tissue pre-processing to create a simpler
matrix for cell capture is required.
Commonly flow cytometry or immunomagnetic selection relies
on negative depletion to remove non-stem cells from the culture
milieu. This technique leaves stem cells without phenotypic
compromise by selection chemistry; however the heterogeneity
of primary tissue renders it impossible to attain homogeneous stem
cell cultures even after several rounds of depletion [24–25].
Positive selection of stem cells is possible, however due to the
nature of flow cytometry both positive and negative populations of
cells will subject to the physical forces of flow cytometric sorting. In
the case of paramagnetic bead isolation, the positive cell fraction
runs the risk of endocytosis of small magnetic particles, which may
render them transcriptionally modified. The derivation of pure
stem cell populations for in vitro characterisation, pre-clinical
research and ultimately translation into regenerative medical
therapeutics remains a rate limiting challenge to the progression of
stem cell medicine and biology.
Here we provide experimental evidence for a novel cell isolation
system for high affinity catch and release of adSCs from minimally
processed adult tissue. This system utilises large, dense separation
beads populated with an antibody binding ligand. The ligand
binds cell-specific antibody in a pH dependent manner permitting
simple cell release with a small shift in reaction pH. Herein this




All studies adhered to UK home office use of animals in
scientific procedures guidelines and were approved by the
Institutional Review Board of the University of Liverpool.
Isolation of stromal vascular fraction (SVF) from rat
adipose tissue
Subcutaneous and visceral adipose were dissected from adult
Wister rats. Primary tissue was washed 3x using PBS, coarsely
macerated using sterile dissection scissors and liquidised by forcing
through a 10 ml syringe. Digestion was achieved by incubation in
0.2% collagenase/PBS (Sigma-Aldrich, UK) (37uC, 90 mins, 50%
v/v collagenase solution/tissue homogenate). After this time had
elapsed the reaction was neutralised by addition of 10% fetal calf
serum. The digest was passed through a 100 mm cell strainer then
centrifuged (400 g, 10 mins). To remove residual erythrocytes,
cells were suspended in 200 ml PBS with 1 ml Optilyse C
(Beckman Coulter, RT, 10 mins). 10 ml PBS was then added to
the erythrolysed cell suspension before a final centrifugation to
recover SVF cells (400 g 10 mins). Resulting cells were suspended
in an appropriate volume of PBS and numerated using a
hemocytometer.
Immunofluorescent staining and FACS analysis
SVF was labelled with FITC conjugated mouse anti rat CD90,
CD29, CD44, CD45, and CD31 (15 mins, 4uC, 1 mg antibody/
105 cells). A FITC conjugated isotype control (IgG1) was used at
the same concentration to allow post-hoc subtraction of non-
antigen-specific fluorescence. The percentage cells in the SVF
fraction expressing these antigens was quantified using flow
cytometry to numerate cells with associated antibody mediated
fluorescence.
CD90+ isolation: protein A-coated beads (non-reversible
antibody binding)
CD90+ cell capture was achieved by labelling cells and loading
Protein A-coated capture beads (50–200 mm diameter, CellCap
Technologies Ltd) with CD90 antibody at the following concen-
trations: 1 mg antibody/105 cells and 1 mg antibody/10 mL beads.
Equal volumes of cell suspensions and beads were incubated in a
final volume of 1 ml PBS with gentle rolling in 1.5 ml
polypropylene tubes on a roller table (30 mins, 4uC). Reactions
in which neither cells nor beads received antibody were performed
as a negative control.
Post bead/cell interaction, the percentage of cells specifically
depleted by specific capture was quantified using flow cytometry,
again based on cellular events associated with antibody mediated
FITC fluorescence.
RNA isolation
The following solutions were prepared prior to RNA isolation
(all reagents Qiagen, UK unless stated otherwise). 44 ml of ACS
grade 100% ethanol was added to 6 ml wash buffer (RPE), while
10 ml of 1 M b-mercaptoethanol (Sigma-Aldrich UK) was added
to 1 ml lysis buffer (RLT).
Prior to RNA extraction cells were washed with PBS
(365 minutes, room temperature). Following this, 350 ml of buffer
RLT was added to each sample and incubated for 5 minutes at
room temperature. Resulting lysates were transferred to QIAsh-
redder columns and spun at 13400 g for 2 minutes. 250 ml of
100% ethanol was added to the elutant, transferred to an RNeasy
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mini column and spun at 13400 g for 15 seconds. 500 ml wash
buffer (RW1) was then added to the column and incubated for
5 minutes at room temperature before being spun at 13400 g for
15 seconds. Following this, 500 ml pre-warmed buffer RPE was
added to the column and spun for 13400 g for 15 seconds. This
step was repeated a second time and spun at 13400 g for
2 minutes. Finally, to elute RNA columns were transferred to
RNase free tubes and 30 ml RNase free ddH2O added, incubated
at room temperature for 2 minutes then spun at 13400 g for
1 minute. Quantity and purity of RNA was determined by
spectrophotometry (260/280 nm absorbance). Only samples that
had a 260/280 nm absorbance between 1.9 and 2.1 were used in
subsequent experiments.
Real-time PCR (qRT-PCR)
Prior to reverse transcription the following stock solutions were
created. Stock 1:1 ml 50 mM Oligo(dt)20, 1 ml 10 mM dNTP
cocktail, 9 ml RNAse free ddH2O. Stock 2:4 ml 5x first strand
buffers, 1 ml 0.1 M DTT, 1 ml RNaseOUT recombinant RNAse
inhibitor (40 U/mL) and 1 ml superscript III RT (200 U/ml). The
above stock solutions were suitable quantities for the reverse
transcription of 2 ml of RNA (15–200 mg/ml RNA).
2 ml of RNA was added to stock 1 denatured at 65uC for
5 minutes followed immediately by a 1 minute chill at 220uC.
Stock 2 was then added, heated for 40 minutes at 50uC, followed
by a further 15 minutes at 70uC. All reagents were purchased from
Invitrogen, UK.
qRT-PCR reactions were assembled containing 2 ml cDNA
diluted 100 fold using molecular biology grade ddH2O, 0.5 ml
sense primer (100 mM), 0.5 ml antisense primer (100 mM), 7.5 ml
Sybr green single tube PCR master mix (Bio-Rad, UK) and 4.5 ml
molecular biology grade ddH2O.
Primers for gene of interest (CD90) and reference gene (b-actin)
were designed in house. (CD90 sense:
CTGCTGAGCCTTTGTGGAC, anti-sense; GCATCTT-
TATTGAGTGTG, TA: 50.1uC. b-actin: sense; GGGACCT-
GACTGACTACCTC, anti-sense; GCCATCTCTTGCTC-
GAAG, TA: 53.9uC).
Reactions were denatured for 3 minutes at 95uC then cycled
40 times at 95uC for 30 seconds, followed by 40 cycles of
annealing; 55uC for 30 seconds, 95uC for 30 seconds and finally
40 cycles at 55uC for 10 seconds. For all qRT-PCR reactions
n = 3/sample. Using inter-experimental variations CD90 tran-
script could be calculated by normalisation to the ubiquitously
expressed b-actin reference gene based on standard threshold
cycle (CT) analysis: 2
–(DCTsample – DCTcontrol) where DCT = CT
gene of interest-CT reference gene.
Primer design
Coding strand cDNA sequences (CDS) of genes of interest were
identified using the genome search platform www.ncbi.nlm.nih.
gov. The CDS sequence was copied into the primer design
platform, Beacon Designer V.7.21 (Premier Biosoft International,
USA). Amplicons of 75–200 bp were selected for optimal
compliance with SYBR green chemistry, along with low
guanine-cytosine (GC) content and an annealing temperature of
55.0+/25.0uC. In addition, all primers were designed between
18–24 bp in length. The proposed primers were verified for
tertiary structures using the DNA mfold server provided by M.
Zuker at http://frontend.bioinfo.rpi.edu/applications/mfold/cgi-
bin/dna-form1.cgi. Primers that formed complex hairpin loops at
the annealing temperature identified by the primer design
platform were discarded as it was unlikely that they would anneal
correctly.
Cross sequence homology was investigated by perfoming a basic
local alignment search (BLAST) was then used to interrogate the
rat genome to identify regions complementary to the designed
primers outside of the target gene. Primers displaying any cross
sequence homology were rejected.
Primers were synthesised at a production scale of 25 nM by
Invitrogen.
CD90+ isolation: mixed-mode ligand-coated beads
(reversible antibody binding)
In order to optimise loading of CD90 FITC-conjugated
antibodies on mixed-mode (i.e. containing both aromatic and
acidic groups) ligand beads (50–200 mm diameter, supplied by
CellCap Technologies Ltd) several buffer configurations were
explored; 200 mM TRIS or 0.1 M phosphate buffer adjusted to
pH 5, 6 or 7.4. In each case beads were washed 3x in buffer before
addition of 1 mg antibody/1 ml beads (15 mins, 4uC). Beads were
then washed three times in the corresponding buffer to remove
unbound antibody and antibody loading confirmed using fluores-
cent microscopy. Release was achieved by incubating beads for
15 mins at 4uC, at either pH 7.4 or 8.4, an additional blocking
variable was also added which included incubation with 10%
rabbit serum for 15 min prior to transfer to release buffer.
Results
Rat SVF characterisation and capture antigen selection
Prior to cell isolation SVF was characterised using a panel of
surface antigens (CD90, CD29, CD44, CD45 and CD31) which
validated CD90+ as the most appropriate target for adSC isolation
from this tissue. Flow cytometry allowed conclusion that of the
antigens analysed, CD90 was the most abundant ranging between
5–10% of total SVF cells, n = 7 (inter-animal repeats) (Fig. 1). It
was also found that the percentage of CD90+ adSCs in SVF did
not vary as a function of anatomical origin of the source material,
with inter-abdominal and subcutaneous adipose yielding identical
adSC (CD90+) concentrations.
CD90+ isolation: protein A-coated beads (non-reversible
antibody binding)
Initial experiments utilised protein A-coated beads (50–200 mm)
to deplete CD90+ cells from SVF. Before cell isolation, loading of
CD90 antibody onto beads was confirmed by exploiting the
antibodies FITC conjugation to visualise antibodies co-localised
with beads using fluorescent microscopy (Fig. 2).
Flow cytometric analysis after cell/bead interaction concluded
that labelling/loading of both cells and beads with antibody
provided the greatest CD90+ depletion and that the antibody
concentration used to load the beads could be considerably
reduced without compromising CD90+ cell depletion. A mean
depletion of 80% was recorded when cells were pre-labelled with
1 mg antibody/105 cells and beads loaded with a very low antibody
concentration; 0.001 mg (Fig. 3). To further confirm CD90+
capture, RNA was isolated from both components of the capture
reaction; beads and surrounding capture supernatents, and qRT-
PCR performed to compare CD90 presence relative to a negative
control capture in which no antibody was added to the system.
This demonstrated that cells bound to the bead surface expressed
CD90 while the contrary was true of the cells which remained
unassociated with beads in the surrounding reaction supernatant.
This showed that CD90+ cells in the reaction mixture were
associated with the bead surface post CD90 targeted cell/bead
interaction (Fig. 4).
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Figure 1. Flow cytometric characterisation of rat primary adipose. A: SVF Characterisation. Error bars represent 1 standard deviation from the
mean, n = 7 (inter-animal repeats). B: Percentage CD90+ cells present in subcutaneous and intra-abdominal adipose tissue. Error bars represent 1
standard deviation from the mean, n = 3 (inter-animal repeats).
doi:10.1371/journal.pone.0053933.g001
Figure 2. Fluorescent microscopic observation of successful CD90 FITC antibody loading of protein A beads.
doi:10.1371/journal.pone.0053933.g002
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CD90+ isolation: mixed-mode ligand-coated beads
(reversible antibody binding)
To evaluate this bead coating it was necessary to replicate
loading of FITC-conjugated CD90 antibody to the surface of
mixed-mode ligand coated beads. These beads are decorated with
an aromatic acid ligand which has the ability to bind and release
Ig in a pH-mediated manner. This suggested them as ideal
candidates for isolation and recovery of cells using antibody reliant
mechanisms [26]. Briefly, antibody loading was investigated using
both TRIS and phosphate buffers at pHs 5, 6 and 7.4 with
Fluorescent microscopy to observe FITC Ig/bead co-localisation.
pHs 5 and 6 facilitated successful antibody loading whilst pH 7.4
did not (Fig. 5). Release of bound antibody was interrogated using
both TRIS and phosphate buffers at pHs 7.4 and 8.4+/– a pre-
release incubation with 10% rabbit serum. optimal release (leaving
no visualisable FITC fluorescence) was observed after pre-
incubating antibody-coated beads with rabbit serum before
transfer to TRIS pH 8.4. This mechanism was found to be
instantaneous.
Ligand beads loaded with either 10 mg or 0.001 mg/ml CD90
antibody were combined with CD90 labelled SVF (1 mg antibody/
105 cells) in 200 mM TRIS, pH 5. Following incubation,
supernatants were subject to flow cytometric analysis, which
revealed depletion of CD90+ cells to an extent comparable to their
Protein A-coated equivalent. Cell laden beads were incubated with
rabbit serum for 15 minutes at 4uC before washing in 200 mM
TRIS pH 8.4 to elute bound cells. The beads were allowed to
settle, supernatant removed and centrifuged for 10 minutes at
1500 rpm. The mean number of recovered cells was 5.66103,
which correlated with the initial population of 5.06103 CD90+
cells/105 cells, n = 4 (Fig. 6). Post-elution the identity of released
cells was confirmed by fluorescent microscopic visualisation of
CD90 FITC conjugated antibody associated with the cell surface
(Fig. 6).
Discussion
adSCs present an untapped source of pluripotent cells for future
medicine. However their isolation and characterisation requires
significant advancement to enable their potential to be realised. An
ideal isolation procedure would facilitate straight forward clinical
translation from a regulatory perspective whilst also fundamentally
increasing first principles biological understanding of the role of
adSCs in normal tissue homeostasis, ageing, wound healing and
chronic disease.
Development of a cell isolation system that provides high purity
and yield whilst avoiding receptor mediated endocytosis of small
immunomagnetic particles and fluidic shear and extreme hydro-
dynamic forces of flow cytometry will provide a superior and
urgently required alternative to today’s widely applied selection
methods. Ideally, an advanced new approach should provide a
homogeneous population without compromising the immunopri-
vilege of autologous cells. The system should perform in complex,
matrix rich primary tissues with minimal preparatory pre-
processing, which can induce cellular transcriptomic and secre-
tomic modifications.
Immunophenotyping has identified a number of adSC surface
molecules, which provide targets to exhume these cells from the
heterogeneous milieu of stromal tissue. We have evidenced using a
relevant animal model that CD90 is the most appropriate
molecule for isolating adSCs. In this rat model CD90 expression
was relatively low ranging between 5–10% compared to previous
reports investigating human adipose adSCs, where approximately
Figure 3. Percentage CD90+ cell depletion as a function of decreasing antibody concentration on capture beads. Antibody
concentration on the cells remained constant; 1 mg antibody/105 cells. X; bead antibody concentration, Y: percentage CD90 cell depletion. Error bars
represent 1 standard deviation, n = 5 (technical replicates). C1 – both cells and beads labelled, C2 – beads alone labeled.
doi:10.1371/journal.pone.0053933.g003
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50% of cells are CD90+ [27–28]. Nevertheless CD90+ cells were
repeatedly identified in the SVF of rat adipose tissue from both the
intra and extra-abdominal regions, which is highly clinically
relevant, demonstrating minimally invasive subcutaneous adipose
(lipoaspirate) is no less potent a source of stem cells than visceral
adipose. This reduces the potential for donor site morbidity during
tissue harvesting associated with considerably more invasive
obtaining of ASCs by bone marrow aspiration.
In this study we used a preparation of large, dense antibody-
loaded beads with diameters ranging from 50–200 mm (manufac-
turer’s specification) as the core of the cell-isolation system.
Previously the use of beads in this size range has not been
considered favourable for isolation of mammalian cells due to an
expectation that binding kinetics would be too slow [29], the cell
loading capacity of the beads would be too low due to a lack of
surface area [29] or there would simply be a lack of interaction
between cells and beads of this size [30]. A previous report on an
end-over-end mixed batch adsorption process using large beads
(mean diameter 61 mm) did not perform well and this was
attributed to poor suspension of the beads, a lack of contact of cells
with the beads and the possibility of mechanical disruption of the
cells on the bead surface [31–32]. In contrast to these earlier
reports we have shown that the use of large beads in a ‘roller
bottle’ format has proved to be a very effective method of cell
capture. We attribute this to the ease with which the large number
of high density beads move through SVF without mechanical
restriction, the repeated sedimentation and resupension cycles that
they go through and the very high affinity of the interaction when
both beads and cell surfaces are populated with antibody. This
implies 2 levels of interaction during capture; the antibody on the
beads interacting with cell surface antigen in addition to the
antibody on the cells binding the Ig specific ligand on the beads.
Initial experiments were with Protein A-coated large beads: this
is a recombinant microbial protein that binds immunoglobulin at
neutral pH; elution can only be achieved at pH ,3 [33]. Protein A
binding affinity can vary between antibody species and sub-class,
however previous studies have demonstrated that Protein A binds
murine IgG with high affinity [34] therefore it was not surprising
Figure 4. qRT-PCR analysis of CD90 fold change relative to a control capture containing no antibody after normalisation to a beta-
actin control. Error bars represent 1 standard deviation from the mean, n = 3 (technical replicates).
doi:10.1371/journal.pone.0053933.g004
Figure 5. Optimisation of appropriate reaction conditions for
cell capture using ligand beads using fluorescent microscopy
to observe ligand particles co-localised with FITC conjugated
antibody across a pH gradient.
doi:10.1371/journal.pone.0053933.g005
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that the murine IgG anti-rat CD90 bound to these Protein A
coated beads. Efficient cell capture was still obtained when beads
were loaded with an incredibly small quantity of antibody. CD90+
cell depletion was reported using flow cytometry, as the essential
technique at the analytical stage to quantify cell capture on a
population scale supported by fluorescent microscopy and qRT-
PCR which identified CD90 transcript specifically associated with
the beads. Collectively this cross referenced and validated this
technique for isolation of CD90+ cells from heterogeneous SVF.
Although isolation of cells with Protein A beads was demon-
strated to be of high efficiency an effective cellular release method
was still required and so an alternative cell capture bead was
explored for this purpose. This bead was modified with a
covalently bound mixed-mode ligand coating based on an
aromatic acid moiety; these ligands bind and release immunoglo-
bins in a pH dependant manner over a narrow range and have
been used in preparative chromatographic processes [26].
Otherwise, the overall structure and density of this mixed mode
ligand bead was identical to the Protein A counterpart. This
investigation successfully demonstrated loading of FITC-conju-
gated antibody onto mixed mode ligand beads at pH5-6, whilst
raising the pH to 8.4 instantly released the antibody and
subsequent bound cells. Pre-incubating ligand beads with an
excess of polyclonal IgG (rabbit serum) prior to release
significantly increased release efficiency. This suggested that
saturating the ligand binding sites on the beads with non-specific
IgG reduced the possibility of multiple interactions with the cell-
specific antibody leading to optimal release kinetics.
This study therefore presents the initial steps in the validation of
a new, minimally invasive stem cell harvesting system. Future
research will focus on confirming and quantifying cell viability and
phenotype maintenance in response to subjection to this novel pH
mediated sorting strategy.
Conclusion
A new approach to isolating highly purified populations of cells
from primary complex mammalian tissues has been experimen-
tally evidenced and validated. The technique marks a technical
breakthrough in derivation of specific cell types based on high
affinity selection. The cell isolation target molecule can be freely
chosen on the basis of what is known about the cell type of choice.
This approach provides a platform technology breakthrough that
has been demonstrated here for adSCs but can by design and
target molecule be tailored to any cell and tissue as required. It was
Figure 6. A: Quantification of released cells using a hemocytometer. Error bars represent 1 standard deviation from the mean, n = 4
(technical replicates) and fluorescent microscopic characterisation of the released cell fraction by observation of CD90 FITC labeling. scale bar
represents 100 mm.
doi:10.1371/journal.pone.0053933.g006
A Novel Technology for Cell Capture and Release
PLOS ONE | www.plosone.org 7 January 2013 | Volume 8 | Issue 1 | e53933
not the authoring research teams intention to ‘‘invent’’ a new
technique for cell isolation however limitations in the currently
available techniques forced new approaches to be considered and
developed to progress delivery of cell based therapies into man and
animals and provide the most relevant in vitro 3D tissue analogues.
The value and novelty in this approach lies in its non-invasive
nature at a cellular level in addition to its ideal physical properties
to be used with minimally processed primary tissue. The ability to
tailor this approach by simply varying the antibody used makes its
applications across cell biology and biomedicine vast. As
demonstrated here this strategy may be used to exploit adipose
as a clinical cell source with straight forward translation based on a
cell population with an absolute minimum of exogenous manip-
ulation prior to delivery.
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